Lilly's Mounjaro and Zepbound continue to power growth as new launches boost momentum amid rising obesity competition.

Q3 2025 Earnings Call November 6, 2025 5:00 PM ESTCompany ParticipantsSeth Blackley - Co-Founder, CEO & DirectorJohn ...

Mounjaro generated sales of $6.5bn in Q3 2025, up 109% from the same period in 2024. Zepbound exhibited even higher growth – up 185% from Q3 2024 – to bring in $3.6bn. Lilly said stronger demand ...

Eli Lilly is partnering with Walmart to offer Zepbound through its direct-to-consumer program, making the popular medication more accessible nationwide.

Iowa’s law putting new regulations on pharmacy benefits managers is temporarily blocked from enforcement for Wellmark Blue Cross-Blue Shield health plans and insurance policies.

Eli Lilly is dropping CVS Health's drug benefit plan for its employees after the healthcare conglomerate stopped covering the company's weight-loss drug in favor of Novo Nordisk's rival medication, ...

As many small businesses weigh their options for health coverage for the new year, the Indiana Chamber of Commerce is touting a new offering for them to consider.

Trividia Health, Inc., announced today that it's TRUE METRIX (R) Self-Monitoring Blood Glucose Systems are now preferred for commercial patients on CVS Caremark Commercial Template Formularies in the ...

If you’ve been to a CVS, a drugstore and pharmacy chain that stretches across the U.S., you’ve probably left with your purchases and an astronomically long receipt. These receipts are rarely under a ...

Lilly is reportedly shifting its 50,000 employees to Rightway, a fintech-driven pharmacy benefit manager, starting January 1.

Philadelphia has sued major pharmacy benefit managers, alleging their marketing and distribution of opioids contributed to the city's opioid crisis. The city seeks damages and corrective actions.